Shares of Shasun Pharmaceuticals gained nearly 4% touching the weekly high of Rs89, after the company said it has concluded the sale of its property at Velachery in South Chennai for a gross consideration of Rs29 crore.
On a consolidated basis, Shasun Pharmaceuticals reported net profit of Rs 24.60 crore for Q3 December 2011, compared with net loss of Rs 9.65 crore in Q3 December 2010. Net sales rose 55% to Rs 302.57 crore in Q3 December 2011 over Q3 December 2010.
....more info
On a consolidated basis, Shasun Pharmaceuticals reported net profit of Rs 24.60 crore for Q3 December 2011, compared with net loss of Rs 9.65 crore in Q3 December 2010. Net sales rose 55% to Rs 302.57 crore in Q3 December 2011 over Q3 December 2010.
....more info